Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Starlynn C Clarke

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Mbio|November 26, 2015
Evolutionary Selection on Barrier Activity: Bar1 Is an Aspartyl Protease with Novel Substrate SpecificityStephen K Jones, Starlynn C Clarke, Charles S Craik, et al.
Plos Pathogens|December 16, 2016
Integrated Activity and Genetic Profiling of Secreted Peptidases in Cryptococcus neoformans Reveals an Aspartyl Peptidase Required for Low pH Survival and VirulenceStarlynn C Clarke, Phillip A Dumesic, Christina M Homer, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
Potency-optimized CD28-activating bispecific antibody for the targeted treatment of Nectin-4 positive cancersManpreet Kaur, Katja Rüger, Elaine C Chen, et al.
Mabs|January 31, 2019
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodiesNathan D Trinklein, Duy Pham, Ute Schellenberger, et al.
Mabs|July 22, 2022
TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activityHarshad S Ugamraj, Kevin Dang, Laure-Hélène Ouisse, et al.
Journal for Immunotherapy of Cancer|June 5, 2021
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine releaseKevin Dang, Giulia Castello, Starlynn C Clarke, et al.
Cell Host & Microbe|May 24, 2016
Intracellular Action of a Secreted Peptide Required for Fungal VirulenceChristina M Homer, Diana K Summers, Alexi I Goranov, et al.
Frontiers in Immunology|May 10, 2018
Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific AntibodiesKatherine E Harris, Shelley Force Aldred, Laura M Davison, et al.
Cytotherapy|April 22, 2023
Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitnessElaine Lau, George Kwong, Tristan W Fowler, et al.
Frontiers in Immunology|January 23, 2019
Multispecific Antibody Development Platform Based on Human Heavy Chain AntibodiesStarlynn C Clarke, Biao Ma, Nathan D Trinklein, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Mbio|November 26, 2015
Evolutionary Selection on Barrier Activity: Bar1 Is an Aspartyl Protease with Novel Substrate SpecificityStephen K Jones, Starlynn C Clarke, Charles S Craik, et al.
Plos Pathogens|December 16, 2016
Integrated Activity and Genetic Profiling of Secreted Peptidases in Cryptococcus neoformans Reveals an Aspartyl Peptidase Required for Low pH Survival and VirulenceStarlynn C Clarke, Phillip A Dumesic, Christina M Homer, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
Potency-optimized CD28-activating bispecific antibody for the targeted treatment of Nectin-4 positive cancersManpreet Kaur, Katja Rüger, Elaine C Chen, et al.
Mabs|January 31, 2019
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodiesNathan D Trinklein, Duy Pham, Ute Schellenberger, et al.
Mabs|July 22, 2022
TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activityHarshad S Ugamraj, Kevin Dang, Laure-Hélène Ouisse, et al.
Journal for Immunotherapy of Cancer|June 5, 2021
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine releaseKevin Dang, Giulia Castello, Starlynn C Clarke, et al.
Cell Host & Microbe|May 24, 2016
Intracellular Action of a Secreted Peptide Required for Fungal VirulenceChristina M Homer, Diana K Summers, Alexi I Goranov, et al.
Frontiers in Immunology|May 10, 2018
Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific AntibodiesKatherine E Harris, Shelley Force Aldred, Laura M Davison, et al.
Cytotherapy|April 22, 2023
Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitnessElaine Lau, George Kwong, Tristan W Fowler, et al.
Frontiers in Immunology|January 23, 2019
Multispecific Antibody Development Platform Based on Human Heavy Chain AntibodiesStarlynn C Clarke, Biao Ma, Nathan D Trinklein, et al.
Pageof 2